FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention relates to drugs and concerns using anastrozole or its pharmaceutically acceptable salt used for decreasing number of cancer relapses and arising a novel contralateral primary tumor in post-climacteric period in women suffering from breast cancer. Also, invention discloses a method for decreasing number of arising cancer relapses and a novel contralateral primary tumor in post-climacteric period in woman suffering from primary breast cancer. Invention allows expanding assortment of agent for control for arising breast cancer relapses.
EFFECT: improved method of cancer treatment.
9 cl, 3 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF FULVESTRANT AT TREATING RESISTANT CANCER OF MAMMARY GLAND | 2001 |
|
RU2265438C2 |
| METHOD FOR PROPHYLAXIS OF MAMMARY CANCER | 1997 |
|
RU2203060C2 |
| METHOD FOR PREDICTING RISK OF BREAST CANCER PROGRESSION WITH UNDERLYING TAMOXIFEN TAKING INTO ACCOUNT EXPRESSION CHARACTERISTICS OF TUMOUR | 2023 |
|
RU2823488C1 |
| METHOD FOR TREATING LUMINAL SUBTYPE OF BREAST CANCER | 2018 |
|
RU2706029C1 |
| 3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD | 2018 |
|
RU2679625C1 |
| PROCESS FOR TREATMENT OF BREAST CANCER USING NERATINIB | 2014 |
|
RU2685715C2 |
| METHODS OF TREATING CANCER | 2016 |
|
RU2737496C2 |
| METHOD FOR PREDICTING BREAST CANCER RECURRENT DURING ENDOCRINE TREATMENT | 2011 |
|
RU2654587C2 |
| METHOD OF DETERMINING PROBABILITY OF RECURRENT BREAST CANCER | 2014 |
|
RU2609199C2 |
| TREATMENT REGIMEN FOR BREAST CANCER USING NERATINIB | 2019 |
|
RU2804713C2 |
